Drug search by name

Insulin degludec and liraglutide and Pancreatitis

Result of checking the interaction of drug Insulin degludec and liraglutide and disease Pancreatitis for safety when used together.

Check result:

Insulin degludec and liraglutide <> Pancreatitis

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of GLP-1 receptor agonists has been associated with rare reports of acute pancreatitis. Other antidiabetic therapies should be considered in patients with a previous history of pancreatitis, although it is not known if they are at increased risk. Patients receiving treatment with GLP-1 receptor agonists should be observed carefully for signs and symptoms of pancreatitis. If this diagnosis is suspected, the treatment should be discontinued immediately and appropriate management should be initiated. Treatment with GLP-1 receptor agonists should be permanently discontinued if pancreatitis is confirmed.

Insulin degludec and liraglutide

Generic Name: insulin degludec / liraglutide

Brand Name: Xultophy

Synonyms: Insulin Degludec and Liraglutide

What is Insulin degludec and liraglutide?